“SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION” (2018) Nirma University Journal of Pharmaceutical Sciences, 5(1), pp. 41–58. doi:10.5281/.